Neoadjuvant Chemotherapy Tied to Improved Ovarian Cancer Survival

In women with advanced ovarian cancer, increased use of neoadjuvant chemotherapy (NACT) followed by surgery — rather than primary cytoreductive surgery — is associated with reduced mortality...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news